Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2Article Published on 2022-10-172022-11-16 Journal: The Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Admission Against booster coronavirus coronavirus 2 COVID-19 Cox proportional hazard Czech Republic declined Delta Effectiveness evade Hospitalization Immunity Infection infections intensive care Logistic regression need for oxygen Odds ratio omicron Omicron variant outcome oxygen Postinfection postinfection immunity protection reached recent respiratory risk SARS-CoV-2 therapy vaccination Vaccine vaccine effectiveness. variant [DOI] 10.1093/infdis/jiac161 PMC 바로가기
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021Article Published on 2022-10-032022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome adjusted Against coronavirus coronavirus 2 coronavirus disease Coverage COVID-19 COVID-19 vaccine Cox proportional hazard Critical Delta dose effective Effectiveness evaluated hazard ratio home Infection maintaining Moderna morbidity and mortality Nursing nursing home residents Pfizer-BioNTech preventing infection provided Rate resident respiratory retrospective cohort SARS-CoV-2 SARS-COV-2 infection second dose vaccination Vaccine vaccine effectiveness. was used [DOI] 10.1093/cid/ciac562 PMC 바로가기
Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort studyArticle Published on 2022-09-222022-11-16 Journal: Nephrology, dialysis, transplantation : official p [Category] SARS, 변종, [키워드] adjusted Admissions age analyzed clinical epidemiology cohort study Comorbidity Course COVID-19 Cox proportional hazard dialysis died disease severity dissemination dominant dose doses driven by Efficacy first dose Hemodialysis high risk Hospitalized incidence Infection information less majority Mild observation period omicron Patient positive predictor variable provided reducing reduction in Regression model risk SARS-CoV-2 SARS-COV-2 infection second dose Severity of infection the epidemic vaccination vaccination. Vaccine vaccine doses variant [DOI] 10.1093/ndt/gfac209 PMC 바로가기
Necessity of Coronavirus Disease 2019 (COVID-19) Vaccination in Persons Who Have Already Had COVID-19이미 COVID-19에 걸린 사람에 대한 코로나바이러스 질병 2019(COVID-19) 예방 접종의 필요성Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] 95% CI Cleveland clinic coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination Cox proportional hazard cumulative incidence demonstrated employee evaluate examined group groups Hospitalization hospitalizations Immunity incidence infected individual Infection lower risk mRNA vaccine multivariable Not demonstrated omicron Omicron variant Person positive provide receiving remained risk risk of COVID-19 SARS-CoV-2 second dose significantly lower subjects symptomatic symptomatic COVID-19 tested uninfected vaccination Vaccines Vaccines. variant [DOI] 10.1093/cid/ciac022 PMC 바로가기 [Article Type] Article
Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June-July 2021중증 급성 호흡기 증후군 코로나바이러스 2 델타(B.1.617.2) 전문 요양 시설 거주자의 변종 발병 및 백신 효과 분석: 2021년 6월-7월 애리조나주 마리코파 카운티에 대한 조사Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted affected assistance B.1.617.2 calculated clinical outcomes complex coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 Coverage COVID-19 Cox proportional hazard Cox proportional hazards models Delta delta variant demographics Department died dose Effectiveness electronic medical record estimate facility health department highest Hospitalized Immunocompromised inclusion criteria infection control investigation Local local public health male median age Medical conditions Messenger RNA mRNA mRNA vaccine Nursing outbreak Outbreaks outcomes positive Public public health rehabilitation resident respiratory SARS-CoV-2 SARS-CoV-2 test severe acute respiratory syndrome Coronavirus skilled nursing facility skilled nursing facility. symptomatic infection tested unique vaccination vaccination rate Vaccination Status Vaccine white [DOI] 10.1093/cid/ciac240 PMC 바로가기 [Article Type] Article
Associations Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants and Risk of Coronavirus Disease 2019 (COVID-19) Hospitalization Among Confirmed Cases in Washington State: A Retrospective Cohort Study워싱턴 주에서 확인된 사례 중 중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2) 변종과 코로나바이러스 질병 2019(COVID-19) 입원 위험 간의 연관성: 후향적 코호트 연구Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Alpha Analysis Beta Chain Reaction collected Confirmed coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 Cox proportional hazard Cox proportional hazards model Delta disease severity Effects Gamma genomic Genomic surveillance hazard ratio hazard ratios hospital Hospitalization Hospitalized include individual Infection Lineage no significant difference omicron pandemic Patient polymerase chain polymerase chain reaction positive proportional hazards model Reporting respiratory resulting retrospective cohort study reverse transcription reverse transcription polymerase chain reaction risk RT-PCR SARS-CoV-2 sequenced Sex specimen Support Surveillance System vaccination variant variants variants. viral genome Washington [DOI] 10.1093/cid/ciac279 PMC 바로가기 [Article Type] Article
Remdesivir Treatment in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19): A Comparative Analysis of In-hospital All-cause Mortality in a Large Multicenter Observational CohortObservational Study Published on 2022-08-242022-10-04 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, [키워드] Admission anticipated baseline benefit Clinical outcome Clinical practice Comparative comparative effectiveness research complement coronavirus disease COVID-19 Cox proportional hazard discharged Effectiveness examined excluded hazard ratio Hospital admission Hospitalization hospitalized COVID-19 patients hospitalized patient initiated invasive mechanical low-flow oxygen lower risk membrane Mortality outcome Oxygenation Patient patients patients died patients hospitalized patients with COVID-19 propensity score matching randomized trials RDV receiving reduction in mortality Remdesivir remdesivir. statistical significance supplemental oxygen Support survival treated Treatment unique Ventilation was used were used with COVID-19 [DOI] 10.1093/cid/ciab875 PMC 바로가기 [Article Type] Observational Study
Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors Research Published on 2022-08-102022-10-05 Journal: Scientific Reports [Category] 바이오마커, 임상, 치료법, 치료제, [키워드] Analysis baseline cardiovascular disease characteristic Characteristics characterized clinical implication clinical parameter Cluster conducted COVID-19 patient COVID-19 patients Cox proportional hazard cumulative mortality diagnostic disease severity fatality Follow-up groups high mortality hospitalized COVID-19 patient implication In-hospital death increase in independent Kaplan–Meier method log-rank test Mortality Neutrophil-to-lymphocyte ratio NLR overlap Patient patients with COVID-19 poor prognosis Predictive value previous study prognostic Prognostic factor quartile Regression model reported risk factor ROC selected significant difference significantly increased survival survival analysis the timing two-dimensional was tested [DOI] 10.1038/s41598-022-17567-4 [Article Type] Research
Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel이스라엘 의료 종사자들 사이에서 SARS-CoV-2 감염 BNT162b 백신 4차 접종 협회Multicenter Study Published on 2022-08-012022-09-11 Journal: JAMA Network Open [Category] SARS, 변종, [키워드] 95% CI adjusted hazard ratio age Analysis benefit BNT162b BNT162b2 BNT162b2 vaccine both groups Breakthrough infection Chain Reaction cohort study COVID-19 COVID-19 infection COVID-19 infections Cox proportional hazard Critical death dose evaluate female hazard ratio HCW HCWs Health care Health care worker health care workers hospital Hospital staff infection rate medical staff Ministry of Health mitigate multicenter cohort study occurred omicron Omicron variant outcome polymerase chain polymerase chain reaction Polymerase chain reaction test positive receiving recipient reduced reduction Regression model Relative risk risk SARS-CoV-2 severe disease Symptom test result tested vaccination vaccination rate Vaccine vaccine dose variant was performed worker [DOI] 10.1001/jamanetworkopen.2022.24657 PMC 바로가기 [Article Type] Multicenter Study
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in ScotlandDelta AY.4.2의 증상이 있는 SARS-CoV-2 감염 및 심각한 COVID-19 결과에 대한 COVID-19 백신 효과: 스코틀랜드의 540만 개인에 대한 코호트 및 테스트 음성 연구Article Published on 2022-07-092022-09-11 Journal: Journal of Global Health [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI 95% confidence interval accounted acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Adults age BNT162b2 ChAdOx1 Chain Reaction cohort study Community conditions conducted confounders contributed coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 admission COVID-19 hospitalisation COVID-19 vaccine Cox proportional hazard Cox proportional hazards model death Delta Effectiveness enhanced Good hazard ratio Hospital admission increased risk individual individuals Infection Lineage mRNA mRNA-1273 mRNA-1273 vaccine mRNA-1273 vaccines offered omicron Omicron variant outcome performed platform polymerase chain polymerase chain reaction proportional hazards model provided reverse transcriptase Reverse transcriptase polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection second vaccination security severe acute respiratory syndrome Coronavirus severe COVID-19 Sex socioeconomic status spline splines symptomatic symptomatic COVID-19 symptomatic infection symptomatic SARS-CoV-2 infection transcriptase United Kingdom vaccination Vaccine vaccine dose Vaccines variant variant of SARS-CoV-2 were infected [DOI] 10.7189/jogh.12.05025 PMC 바로가기 [Article Type] Article